Michael Werth Appointed CEO of DWK Life Sciences

DWK Life Sciences, a major player in the life sciences industry known for its precision glassware and packaging solutions, transitions to new leadership. Michael Werth takes the reins as CEO after Armin Reiche’s 25-year tenure. Reiche will continue to influence the company’s strategic direction as a member of the Advisory Board, ensuring a seamless transition. This leadership change is poised to enhance the firm’s innovative trajectory and industry impact.

Headquartered in Wertheim, Germany, DWK Life Sciences is a global leader in manufacturing precision labware and packaging solutions for pharmaceuticals and industrial use. With renowned brands such as DURAN®, WHEATON®, and KIMBLE®, the company supports diverse sectors, from healthcare to industrial markets. Werth’s extensive international leadership experience, including notable roles at Heraeus Group and General Electric, positions him to elevate DWK’s market strength. His Six Sigma Black Belt certification promises a data-driven approach, aiming to boost efficiency across operations. The innovation and agility he plans to bring will further align the company’s global market presence with growing demands in life sciences. 

The appointment of Michael Werth marks a significant evolution for DWK Life Sciences, promising fresh momentum and a renewed customer focus. With a longstanding tradition of excellence, Werth aims to drive DWK toward greater agility and innovation. As DWK enters this new chapter, the company’s commitment to advancing its global leadership remains strong, promising exciting developments in the life sciences industry.